ABCD2
Basic information
Region (hg38): 12:39550033-39619803
Previous symbols: [ "ALDL1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 28 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 1 | 0 |
Variants in ABCD2
This is a list of pathogenic ClinVar variants found in the ABCD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-39553926-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
12-39553995-G-T | not specified | Uncertain significance (Oct 20, 2023) | ||
12-39553996-C-A | not specified | Uncertain significance (Aug 12, 2022) | ||
12-39554084-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
12-39573755-C-G | not specified | Uncertain significance (Nov 22, 2023) | ||
12-39573792-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
12-39573859-C-G | Benign (-) | |||
12-39586185-C-T | not specified | Uncertain significance (Feb 10, 2023) | ||
12-39586196-A-G | not specified | Uncertain significance (Dec 05, 2022) | ||
12-39586200-G-A | not specified | Likely benign (Feb 11, 2022) | ||
12-39586203-C-T | not specified | Uncertain significance (Aug 26, 2022) | ||
12-39586224-C-T | not specified | Uncertain significance (May 26, 2024) | ||
12-39586276-A-C | not specified | Uncertain significance (Apr 28, 2023) | ||
12-39603924-C-A | not specified | Uncertain significance (Aug 28, 2023) | ||
12-39603937-A-G | not specified | Uncertain significance (Nov 23, 2022) | ||
12-39603991-A-G | not specified | Uncertain significance (Jun 13, 2023) | ||
12-39603996-A-C | not specified | Uncertain significance (Sep 14, 2021) | ||
12-39604797-A-G | not specified | Uncertain significance (May 10, 2024) | ||
12-39604840-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
12-39607655-T-G | not specified | Uncertain significance (Nov 03, 2023) | ||
12-39607681-C-T | not specified | Uncertain significance (Jun 21, 2023) | ||
12-39617049-G-T | not specified | Uncertain significance (Jul 19, 2023) | ||
12-39617093-A-G | not specified | Uncertain significance (May 26, 2023) | ||
12-39617099-G-A | not specified | Uncertain significance (Jun 17, 2022) | ||
12-39618736-A-G | not specified | Uncertain significance (Dec 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABCD2 | protein_coding | protein_coding | ENST00000308666 | 10 | 69719 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000471 | 0.998 | 125715 | 0 | 33 | 125748 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.35 | 267 | 399 | 0.669 | 0.0000200 | 4830 |
Missense in Polyphen | 65 | 124.62 | 0.52157 | 1449 | ||
Synonymous | 0.447 | 133 | 140 | 0.952 | 0.00000686 | 1448 |
Loss of Function | 2.77 | 14 | 30.5 | 0.459 | 0.00000142 | 410 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000439 | 0.000438 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000134 | 0.000132 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Probable transporter.;
- Pathway
- Peroxisome - Homo sapiens (human);ABC transporters - Homo sapiens (human);Beta Oxidation of Very Long Chain Fatty Acids;Oxidation of Branched Chain Fatty Acids;Refsum Disease;Phytanic Acid Peroxisomal Oxidation;Adrenoleukodystrophy, X-linked;Carnitine-acylcarnitine translocase deficiency;Nuclear Receptors in Lipid Metabolism and Toxicity;ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport
(Consensus)
Recessive Scores
- pRec
- 0.199
Intolerance Scores
- loftool
- 0.233
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.92
Haploinsufficiency Scores
- pHI
- 0.0848
- hipred
- N
- hipred_score
- 0.317
- ghis
- 0.470
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.929
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Abcd2
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- very long-chain fatty acid metabolic process;fatty acid beta-oxidation;long-chain fatty acid transport;positive regulation of fatty acid beta-oxidation;very long-chain fatty acid catabolic process;myelin maintenance;transmembrane transport;negative regulation of cytokine production involved in inflammatory response;negative regulation of reactive oxygen species biosynthetic process;neuron projection maintenance;positive regulation of unsaturated fatty acid biosynthetic process
- Cellular component
- peroxisome;peroxisomal membrane;cytosol;integral component of membrane
- Molecular function
- long-chain fatty acid transporter activity;protein binding;ATP binding;ATPase activity, coupled to transmembrane movement of substances;protein homodimerization activity